Mochida links with Mitsubishi Tanabe for escitalopram
This article was originally published in Scrip
Executive Summary
Mitsubishi Tanabe Pharma (MTP) has entered into an agreement for the co-marketing of the selective serotonin reuptake inhibitor escitalopram in Japan.